CPIX
NASDAQ
US
Cumberland Pharmaceuticals Inc. - Common Stock
$3.17
▲ +$0.07
(+2.26%)
Vol 81K
7
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$59.5M
ROE
-12.6%
Margin
-8.1%
D/E
20.06
Beta
-0.44
52W
$2–$7
Wall Street Consensus
6 analysts · Apr 20260
Strong Buy
0
Buy
3
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 0.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | — | $-0.01 | — |
| Sep 2025 | — | $-0.06 | — |
| Jun 2025 | — | $0.02 | — |
| Mar 2025 | — | $0.16 | — |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $10.4M | $11.7M | $10.8M | $8.3M | $13.7M |
| Net Income | — | -$1.9M | $1.3M | -$741K | -$1.9M | -$1.4M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -11.2% | -11.2% | -11.2% | -11.2% | -12.6% | -12.6% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -6.8% | -7.0% | -7.0% | -7.0% | -8.1% | -8.1% |
| Gross Margin | 81.4% | 84.0% | 84.0% | 84.0% | 84.5% | 84.5% |
| D/E Ratio | 18.72 | 18.72 | 18.72 | 18.72 | 20.06 | 20.06 |
| Current Ratio | 1.30 | 1.30 | 1.30 | 1.30 | 1.23 | 1.23 |
Key Ratios
ROA (TTM)
-4.8%
P/S (TTM)
1.44
P/B
1.5
EPS (TTM)
$-0.23
CF/Share
$0.12
Rev Growth 3Y
+1.7%
52W High
$7.25
52W Low
$1.85
$1.85
52-Week Range
$7.25
Financial Health
Free Cash Flow
-$41K
Net Debt
-$1.3M
Cash
$11.4M
Total Debt
$10.2M
As of Dec 31, 2025
How does CPIX compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
CPIX valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
1.4
▼
71%
below
peers
(5.0)
vs Peers
vs Industry
Undervalued
P/B ratio
1.5
▼
31%
below
peers
(2.1)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
CPIX profitability vs Pharmaceuticals peers
ROE
-12.6%
▲
77%
above
peers
(-54.3%)
vs Peers
vs Industry
Top tier
Net margin
-8.1%
▲
83%
above
peers
(-47.4%)
vs Peers
vs Industry
Below avg
Gross margin
84.5%
▲
24%
above
peers
(68.3%)
vs Peers
vs Industry
Weak
ROA
-4.8%
▲
87%
above
peers
(-37.4%)
vs Peers
vs Industry
Top tier
CPIX financial health vs Pharmaceuticals peers
D/E ratio
20.1
▲
1203%
above
peers
(1.5)
vs Peers
vs Industry
High debt
Current ratio
1.2
▼
63%
below
peers
(3.4)
vs Peers
vs Industry
Low liquidity
Beta
-0.4
▼
147%
below
peers
(0.9)
vs Peers
vs Industry
More volatile
CPIX fundamentals radar
CPIX
Peer median
Industry
CPIX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
CPIX vs peers: key metrics
Insider Activity
NeutralBuys
0
Sells
0
GALANTE JOSEPH C.
Director · Mar 18
1800 shs
BROWN MARTIN S JR
Director · Mar 18
1800 shs
JONES JAMES R
Director · Mar 18
1800 shs
YOUNG CAROLINE R
Director · Mar 18
1800 shs
KROGULSKI KENNETH J
Director · Mar 18
5800 shs
Last 90 days
Top Holders
Top 5: 13.73%Ikarian Capital, LLC
3.72%
$1.7M
Renaissance Technologies, L…
3.16%
$1.4M
Vanguard Group Inc
2.75%
$1.3M
Perceptive Advisors Llc
2.28%
$1.0M
Dimensional Fund Advisors LP
1.82%
$836K
As of Dec 31, 2025
Latest News
No related news yet